신경 랩 시장 규모, 점유율, 동향 분석 리포트 : 수술별, 용도별, 지역별, 부문 예측(2025-2030년)

Nerve Wrap Market Size & Trends:

The global nerve wrap market size was estimated at USD 198.31 million in 2024 and is projected to grow at a CAGR of 9.13% from 2025 to 2030. This market growth is largely attributed to the increasing prevalence of peripheral nerve injuries (PNIs) and the rising adoption of advanced surgical solutions for nerve repair.

Nerve wraps are increasingly used to prevent scar tissue formation and to promote optimal nerve regeneration post-surgery. According to Barrow Neurological Institute, most PNIs occur in the upper extremities, particularly the wrists and hands, where nerve wraps have demonstrated clinical efficacy in improving patient outcomes. As healthcare providers prioritize minimally invasive and effective nerve repair strategies, the demand for nerve wraps is expected to rise steadily throughout the forecast period.

The growing number of traumatic injuries, surgical procedures, and nerve compression syndromes, such as carpal tunnel syndrome, has significantly increased the demand for nerve protection and regeneration solutions such as nerve wraps. According to a report published by the National Institutes of Health (NIH), in October 2022, approximately 2.4% of the global population is affected by peripheral nerve disorders, with the prevalence rising to 8% among older adults. Moreover, according to a report by NIH in August 2023, nerve compression syndrome is a commonly reported condition in the general population, with severity ranging from mild discomfort to severe impairment.

Chronic conditions such as diabetes are major contributors to nerve damage, often resulting in neuropathy. The global rise in diabetes prevalence, particularly type 2 diabetes, is directly correlated with an increasing demand for nerve repair and protective solutions. As per the Cleveland Clinic, Type 2 diabetes is the most common form, representing 90% to 95% of all diabetes cases, driving the nerve wrap market growth.

Minimally invasive surgical methods are increasingly preferred in peripheral nerve repair because of advantages such as reduced infection risk, faster recovery, and lower postoperative pain. Nerve wraps enhance these processes by covering the repaired nerve, lessening tension, and inhibiting scar tissue formation, resulting in enhanced functional recovery and long-term results. These advancements enhance safer and more effective surgeries and encourage broader nerve wrap application in clinical settings.

Global Nerve Wrap Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2030. For this study, Grand View Research has segmented the global nerve wrap market report based on surgery, application, and region.

• Surgery Outlook (Revenue, USD Million, 2025 - 2030)
• Direct Nerve Repair
• Nerve Grafting
• Application Outlook (Revenue, USD Million, 2025 - 2030)
• Lower Extremities
• Upper Extremities
• Regional Outlook (Revenue, USD Million, 2025 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Surgery
  • 1.2.2. Application
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Surgery and Application outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Nerve Wrap Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Nerve Wrap Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Pipeline Analysis

Chapter 4. Global Nerve Wrap Market: Surgery Estimates & Trend Analysis

• 4.1. Global Nerve Wrap Market: Surgery Dashboard
• 4.2. Global Nerve Wrap Market: Surgery Movement Analysis
• 4.3. Global Nerve Wrap Market by Surgery, Revenue
• 4.4. Direct Nerve Repair
  • 4.4.1. Direct nerve repair market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Nerve Grafting
  • 4.5.1. Nerve grafting market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Nerve Wrap Market: Application Estimates & Trend Analysis

• 5.1. Global Nerve Wrap Market: Application Dashboard
• 5.2. Global Nerve Wrap Market: Application Movement Analysis
• 5.3. Global Nerve Wrap Market by Application, Revenue
• 5.4. Lower Extremities
  • 5.4.1. Lower extremities market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Upper Extremities
  • 5.5.1. Upper extremities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Nerve Wrap Market: Regional Estimates & Trend Analysis by Surgery, Application, and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 61.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Axogen Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Surgery benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Stryker
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Surgery benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Polyganics BV
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Surgery benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Integra LifeSciences Corporation.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Surgery benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Newrotex
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Surgery benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. AdvaCare Pharma
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Surgery benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Orthocell Ltd
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Surgery benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. BioCircuit Technologies
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Surgery benchmarking
    • 7.3.11.4. Strategic initiatives